Drug intelligence / Profile preview

kanamycin + metronidazole

Development stage
Preclinical
Lead developer
Kitasato Institute
Modality
Small Molecules
Administration
Topical, Intravenous
01

Overview

Kanamycin + metronidazole is a synergistic antibiotic combination that demonstrates enhanced efficacy against various bacterial infections. Kanamycin is an aminoglycoside that prevents bacterial protein synthesis by binding to 16S rRNA of the 30S ribosomal subunit, while metronidazole is reduced to cytotoxic compounds that cause DNA damage in bacteria. When combined, these antibiotics show significant synergy with drastically reduced minimum inhibitory concentrations, allowing for lower doses while maintaining or enhancing antimicrobial activity. This combination is effective against a wide spectrum of pathogens including gram-positive and gram-negative bacteria, anaerobic bacteria, and certain protozoa.

Brand names
General Trio Powder
Other names
super drugsuper cure
02

Targets

Bacterial Ribosome

Beyond the preview

Go deeper on kanamycin + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on kanamycin + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call